Calypte Biomedical Corporation

Calypte Biomedical Corporation is dedicated to developing and marketing in vitro testing algorithms for improved diagnosis of HIV infection, STDs, and other chronic diseases. Calypte is a pioneer in the development of non-blood assays for HIV antibody determination, and is the first and only company to achieve USFDA approval of a urine-based HIV-1 antibody screening test and supplemental Western Blot. Following the success of the Calypte urine-based HIV-1 antibody testing algorithm used in laboratories, Calypte is now commercializing Aware™ rapid tests for the determination of HIV 1/2 antibodies in blood, urine, and oral fluid. Calypte has developed these three 20-minute tests to offer unrivalled testing flexibility in a non-laboratory setting. Realizing that no single approach to HIV testing will meet the needs of every testing environment, Calypte has developed three different testing solutions, at least one of which should be well suited to a given testing and counseling setting.

Contact Details: 5 Centerpointe Drive, Suite 400 Lake Oswego OR 97035 United States of America Tel: (1) 971-204-0282 Fax: (1) 971-204-0284 Email: customerservice@calypte.com WWW: www.calypte.com/

Loading...

Recent Publications by Calypte Biomedical Corporation:
Report of the Task Force on the future of OTC drugs. OBJECTIVE: To evaluate the accuracy, utility, and cost effectiveness of a...	27th September, 2002	Calypte Biomedical, USA.	Food Drug Law J. 2000;55(1):27-31.

Press Releases on Calypte Biomedical Corporation:
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015	18th November, 2009	Reportlinker	NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Global In Vitro Diagnostics Investment Opportunities, Analysis and
Reportlinker Adds Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads	5th November, 2009	Reportlinker	NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads

BioNews Results for Calypte Biomedical Corporation:
Calypte Biomedical Announces Changes to its Board of Directors	Pharma Live:  Sep 25 2009 4:43PM Matching: calypte biomedical

Calypte Biomedical Corporation (CBMC.OB) Financial information Links from Barchart
CBMC.OB Quote from from Barchart.com
CBMC.OB Chart from from Barchart.com
CBMC.OB Profile from from Barchart.com
CBMC.OB Opinion from from Barchart.com
→View more Calypte Biomedical Corporation finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 433 times since April 2007, the link to the organisation's website has been followed 65 times

Recent Search Terms used to find this page: calypte board of directors | calypte life sciences 2009 | CALYPTE BIOMEDICAL CORPORATION | calypte biomedical | calypte biomedical 2009 | calypte biomedical | Calypte -hummingbird | calypte biomedical | calypte press release 2009 | calypte biomedical | .

Search for more companies in Lake Oswego

Search for more companies in OR

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Calypte Biomedical Corporation